1. Home
  2. CMPX vs EVEX Comparison

CMPX vs EVEX Comparison

Compare CMPX & EVEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$1.84

Market Cap

927.5M

Sector

Health Care

ML Signal

HOLD

Logo Eve Holding Inc.

EVEX

Eve Holding Inc.

HOLD

Current Price

$2.89

Market Cap

835.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMPX
EVEX
Founded
2014
2020
Country
United States
United States
Employees
N/A
198
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
927.5M
835.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
CMPX
EVEX
Price
$1.84
$2.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
5
Target Price
$14.57
$6.88
AVG Volume (30 Days)
12.2M
1.3M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$934.41
$11,676.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.61
$2.34
52 Week High
$6.88
$7.70

Technical Indicators

Market Signals
Indicator
CMPX
EVEX
Relative Strength Index (RSI) 26.23 46.58
Support Level $1.61 $2.86
Resistance Level $3.54 $3.18
Average True Range (ATR) 0.15 0.21
MACD 0.06 -0.01
Stochastic Oscillator 46.05 34.52

Price Performance

Historical Comparison
CMPX
EVEX

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

About EVEX Eve Holding Inc.

Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment, a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.

Share on Social Networks: